Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 54, Issue 8

Issues

Analytical interference by monoclonal immunoglobulins on the direct bilirubin AU Beckman Coulter assay: the benefit of unsuspected diagnosis from spurious results

Elena García-González / Ricardo González-Tarancón / Maite Aramendía / Luis Rello
Published Online: 2015-12-17 | DOI: https://doi.org/10.1515/cclm-2015-0608

Abstract

Background: Monoclonal (M) components can interfere with the direct bilirubin (D-Bil) assay on the AU Beckman Coulter instrumentation and produce spurious results, such as D-Bil values greater than total bilirubin (T-Bil) or very low/negative D-Bil values. If properly detected, this interference may uncover undiagnosed patients with monoclonal gammopathy (MG).

Methods: We investigated the interference rate on the D-Bil AU assay in serum samples known to contain M proteins along with their isotype and described the protocol set up in our laboratory to help with the diagnosis of MG based on D-Bil spurious results as first indication.

Results: During a period of 4 years, 15.4% (345 of 2235) of serum samples containing M immunoglobulins produced erroneous D-Bil results, although no clear relationship between the magnitude or isotype of the M component and interference could be found. In total 22 new patients were diagnosed with MG based on the analytical artefact with the D-Bil as first indication.

Conclusions: The D-Bil interference from MG on the Beckman AU analysers needs to be made known to laboratories in order to prevent clinical confusion and/or additional workup to explain the origin of anomalous results. Although this information may not add to the management of existing patients with serum paraproteins, it can benefit patients that have not been diagnosed with MG by triggering follow up testing to determine if M components are present.

Keywords: direct bilirubin; interference; monoclonal component; monoclonal gammopathy; paraprotein

References

  • 1.

    Kroll MH, Elin RJ. Interference with clinical laboratory analyses. Clin Chem 1994;40:1996–2005.Google Scholar

  • 2.

    Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev 2004;25:105–20.Google Scholar

  • 3.

    Bakker AJ, Mücke M. Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention. Clin Chem Lab Med 2007;45:1240–3.Web of ScienceGoogle Scholar

  • 4.

    Dalal BI, Brigden ML. Factitious biochemical measurements resulting from hematologic conditions. Am J Clin Pathol 2009;131:195–204.Google Scholar

  • 5.

    Pantanowitz L, Horowitz GL, Upalakalin JN, Beckwith BA. Artifactual hyperbilirubinemia due to paraprotein interference. Arch Pathol Lab Med 2003;127:55–9.Google Scholar

  • 6.

    Yang Y, Howanitz PJ, Howanitz JH, Gorfajn H, Wong K. Paraproteins are a common cause of interferences with automated chemistry methods. Arch Pathol Lab Med 2008;132:217–23.Google Scholar

  • 7.

    Nauti A, Barassi A, Merlini G, d’Eril GV. Paraprotein interference in an assay of conjugated bilirubin. Clin Chem 2005;51:1076–7.Google Scholar

  • 8.

    Song L, Kelly KA, Butch AW. Monoclonal and polyclonal immunoglobulin interference in a conjugated bilirubin assay. Arch Pathol Lab Med 2014;138:950–4.Google Scholar

  • 9.

    Seimiya M, Suzuki Y, Yoshida T, Sawabe Y, Matsushita K, Nomura F. The abnormal reaction data-detecting function of the automated biochemical analyzer was useful to prevent erroneous total-bilirubin measurement and to identify monoclonal proteins. Clin Chim Acta 2015;441:44–6.Web of ScienceGoogle Scholar

  • 10.

    Jelinek AG, Bachmann LM. Unexpected test results in a patient with multiple myeloma. Clin Chem 2014;60:1375–8.Web of ScienceGoogle Scholar

  • 11.

    Wadhera RK, Rajkumar SV. Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin Proc 2010;85:933–42.Web of ScienceGoogle Scholar

  • 12.

    Kyle RA, Rajkumar SV. Monoclonal gammopathies of undetermined significance. Best Pract Res Clin Haematol 2005;18:689–707.Google Scholar

  • 13.

    Monk C, Wallage M, Wassell J, Whiteway A, James J, Beetham R. A monoclonal protein identified by an anomalous lipaemia index. Ann Clin Biochem 2009;46:250–2.Google Scholar

About the article

Corresponding author: Luis Rello, Department of Clinical Biochemistry, “Miguel Servet” University Hospital, Paseo Isabel La Católica 1-3, 50009, Zaragoza, Spain, Phone: +34 976765544, Fax: +34 976765543, E-mail:


Received: 2015-06-28

Accepted: 2015-11-11

Published Online: 2015-12-17

Published in Print: 2016-08-01


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organisation(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 54, Issue 8, Pages 1329–1335, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2015-0608.

Export Citation

©2016 by De Gruyter.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Rosa M. López Martínez, Raúl Rigo Bonnin, M. José Andrés Otero, Francesca Canalias Reverter, Ruth Cano Corres, Sara Esteve Poblador, F. Javier Gella Tomás, Bernardino González de la Presa, and Inmaculada Pérez de Algaba Fuentes
Revista del Laboratorio Clínico, 2017
[2]
Neha Dhungana, Cory Morris, and Matthew D. Krasowski
Practical Laboratory Medicine, 2017, Volume 8, Page 77
[3]
Nassima Belaidi, Agnès Georges, Isabelle Lacroix, Anne Croisonnier, Véronique Ducros, Jean-Claude Souberbielle, and Jean-Benoît Corcuff
Clinica Chimica Acta, 2016, Volume 457, Page 123

Comments (0)

Please log in or register to comment.
Log in